We are attempting to develop methods for the sequencing of glycosaminoglycans from their reducing end. Here we describe a procedure for the analysis of dermatan sulphate from pig skin. The glycosaminoglycan is released from its parent proteoglycan by exhaustive proteolysis by using both endo-and exo-peptidases. The amino group of the residual serine residue is conjugated with a p-hydroxyphenyl group, which in turn is iodinated with 1251 (the Bolton-Hunter reagent, BHR). The ion-exchange-purified end-labelled dermatan sulphate is then degraded partially or completely by various enzymic or chemical means to yield fragments extending from the labelled serine residue to the point of cleavage. The various products are separated by gradient PAGE, detected by autoradiography and quantified by videodensitometry. Complete digestion with chondroitin ABC lyase affords the labelled fragment AHexA-GalNAc(-SO4)-GlcA-Gal-Gal-XylSer(-BHR). The structure was confirmed by sequential degradation from the non-reducing end by chondroitin AC lyase, HgCl2, and ,-galactosidase. Periodate oxidation cleaves most of the Xyl even without treatment with alkaline phosphatase, showing that Xyl is not substituted with phosphate. Results from partial and selective periodate oxidation indicate that most of the non-sulphated IdoA residues are located towards the non-reducing end. Partial or complete digestions with testicular hyaluronidase (in the presence of an excess of,-glucuronidase) or chondroitin AC lyase identify the positions of GlcA residues. The results confirm that HexA next to Gal is always GlcA. Moreover, GlcA is common in the first three disaccharide repeats. Results with testicular hyaluronidase indicate that the distribution of clustered GlcA-GalNAc repeats is periodic and peaks at positions 1-3, 8-9 and around 25. Although there must be chains that contain IdoA in nearly all of the available positions, regions that have not been fully processed during biosynthesis are markedly non-random.
INTRODUCTION
Proteoglycans, which consist of a central protein core substituted with sulphated polysaccharide side chains, occur in the intercellular matrix, at the cell surface and in intracellular storage granules [for reviews see Fransson (1987) , Heinegard & Sommarin (1987) and Ruoslahti (1988) ]. The proteoglycans are diverse in structure as well as function. Their core proteins may vary in Mr from 11000 to 220000 (Ruoslahti, 1988) , and the number of side chains from one to 100 (Heinegard & Sommarin, 1987) . The proteoglycans participate in extracellular-matrix assembly, cell adhesion and growth control. Both the protein and the glycan side chains are involved in these processes.
The glycan side chains, termed glycosaminoglycans, are generally linked via their reducing ends to hydroxy amino acid residues of the core protein. A common linkage sequence is -GlcA-Gal-Gal-Xyl-Ser-(for reviews see Fransson, , 1987 . The Xyl residue may be 2-phosphorylated, which has been shown for chondroitin sulphate (Oegema et al., 1984) , heparan sulphate , dermatan sulphate (Gl6ssl et al., 1986) and heparin (Rosenfeld & Danishefsky, 1988) . Biosynthesis of the glycan chains proceeds by repeated alternating addition of hexosamine and uronic acid residues at the non-reducing end. Because there is no precise termination mechanism, the chains display considerable length polydispersity. After polymerization the chains are modified into their final structure by uronosyl epimerase and various sulphotransferases. Dermatan sulphate is formed when the D-GlcA residues of the chondroitin precursor are extensively epimerized to L-IdoA (L-iduronic acid) before sulphation (Malmstr6m & Aberg, 1982) .
The structural variability of the glycosaminoglycan side chains of proteoglycans must be controlled in some manner, as structures with specific properties can be reproducibly formed, notably the antithrombin-binding sequence in heparin , the contact zones for dermatan sulphate or heparan sulphate self-association (Fransson, 1987) and the features that confer antiproliferative activity on to heparin (Wright et al., 1989) . However, it is not known whether the majority of the different disaccharide repeats in glycosaminoglycans are distributed randomly or in some ordered fashion. The disaccharide sequence of a glycan can be determined either from the non-reducing or from the reducing end. We are attempting to develop methods that would permit sequencing from the reducing end. In the present paper we describe a method for the sequencing of dermatan sulphates obtained after exhaustive proteolysis. The results indicate that clustered D-GlcA-GalNAc repeats are distributed periodically in a non-random fashion. (EC 4.2.2.4) , chondroitin AC-I lyase and AC-TI lyase (EC 4.2.2.5; all from ICN Biomedicals), testicular hyaluronidase (EC 3.2.1.35; 15000 units/mg, from Leo, Helsingborg, Sweden), /J-D-glucuronidase (EC 3.2.1.31; Sigma grade B-10) and ,-D-galactosidase (EC 3.2.1.23; Sigma grade IX). Another enzyme was alkaline phosphatase (EC 3.1.3.1; Sigma type III).
The following special chemicals were used: sulphosuccinimidyl 3-(4-hydroxyphenyl)propionate (sulpho-SHPP from Pierce Chemical Co.), acrylamide and NN'-methylenebisacrylamide (Serva), NNN'N'-tetramethylethylenediamine (Sigma Chemical Co), Na125I (specific radioactivity 1.7 x 104 Ci/g, > 98 % pure; Cintichem, Tuxedo, NY, U.S.A.) and chloramine-T (BDH Chemicals); other chemicals were of AnalaR grade.
The The various preparations of proteolytic enzymes were assayed for the presence of phosphatase activity by using p-nitrophenyl phosphate in 50 mM-Tris/HCl buffer pH 8.0, as a substrate. Incubations were carried out for 1 h at 37°C, the pH was raised to 10 by the addition of 1 M-NaOH and the A410 was recorded. The procedure was standardized with alkaline phosphatase.
Preparation of linkage-region fragments
Dermatan sulphate preparation DS-36, which was obtained after proteolysis with papain, was digested exhaustively with chondroitin ABC lyase; 500 mg in 25 ml of 10 mM-EDTA/0. 1 MTris-acetate buffer, pH 7.3, and dialysed against the same buffer, was treated with 500 munits of enzyme at 37°C for 24 h. Samples were checked for u.v. absorption at 232 nm. The solution was further digested overnight by the addition of 50 munit portions of enzyme until the u.v. absorption remained constant (four additions). The digest was chromatographed in 25 1 ml portions on a fast-desalting column (FD-G-25) connected to a Pharmacia-LKB f.p.l.c. system (Lindblom et al., 1989) and eluted with MilliQ water at a rate of I ml/min. The effluent was analysed for u.v.-absorbing material (A232) with a variablewavelength detector (LKB 2151) connected to an LKB 2210 recorder. Material that appeared in the disaccharide position and material of larger size were pooled separately and freeze-dried. The latter material (12 mg) was subjected to ion-exchange h.p.l.c. on a 3 ml PartiSil 10 SAX column connected to a Varian Vista 5500 liquid chromatograph containing a UV-200 detector. The column was eluted with a gradient of 0-0.6 M-potassium phosphate buffer, pH 4.3, at rate of 1 ml/min. The effluent was also analysed for orcinol-positive material (Fransson, 1968) . Radioiodination of dermatan sulphate preparations with Bolton-Hunter reagent (BHR)
The pig skin dermatan sulphate preparations and DS-36 have been analysed elsewhere (Fransson et al., 1979) . has an Mn of 17 500 and a very low GlcA content, probably only one to three residues per chain, whereas DS-36 has an Mn of 14500 and approx. seven or eight GlcA residues per chain. Both preparations were subjected to exhaustive proteolytic procedures (see above), and 3-(4-hydroxyphenyl)propionylated at the Nterminus of the residual Ser 
Step 1. Dermatan sulphate (0.5-5 mg) was dissolved in 0.1 M-sodium borate buffer, pH 8.5 (400 ,ug/,tl) , and shaken at room temperature overnight with sulphosuccinimidyl 3-(4-hydroxyphenyl)propionate (100 ,tg/,ll). After addition of 2 ,ul of 0.2 M-glycine in borate buffer per ,ul of reaction mixture, dialysis against water and freeze-drying, samples were dissolved in 50 mM-Tris/HCI buffer, pH 7.5, to a final concentration of approx. 10-20 mg/ml. The preparations contained 0.8-1 mol of hydroxyphenyl group/mol of dermatan sulphate. This was assessed from the A275 by using either tyrosine or hydroxyphenylsuccinimide (treated with water) as a standard and unmodified dermatan sulphate as a blank.
Step 2. Portions (10 ,ug-2 mg) of 3-(4-hydroxyphenyl)-propionylated dermatan sulphate in 100-200 ,ul of 50 mmTris/HCl buffer, pH 7.5, were mixed with 0.2-0.4 mCi of Na'251 and 20 ,ul of chloramine-T solution (0.6 mg/ml of 50 mmTris/HCI buffer, pH 7.5). After 2 min at room temperature the reaction was terminated by the addition of 200 ,ul of Na2S2O5 solution (1.2 mg/ml of Tris buffer) followed by 400,l of KI solution (10 mg/ml). The reaction mixtures were applied to columns (1 ml) of DE-53 DEAE-cellulose equilibrated in 6 Murea/0.2 M-sodium acetate buffer, pH 5.8, which were then washed with 5 bed-volumes of the equilibrating buffer, followed by the same buffer containing 0.5 M-sodium acetate and by 50 mM-Tris/HCl buffer, pH 7.5, to remove non-glycosaminoglycan material. The radiolabelled dermatan sulphate was displaced with five 1 ml portions of 4 M-guanidinium chloride/ 50 mM-sodium acetate buffer, pH 5.8. The effluent was analysed for 1251 with an LKB 1271 RiaGamma counter. Radiolabelled dermatan sulphate was recovered by precipitation with 3 vol. of 95 % (v/v) ethanol at -20°C , centrifuged, redissolved in 100 ,ul of 25 % (w/v) sodium acetate, reprecipitated with 1 ml ofethanol, centrifuged, washed with absolute ethanol, re-centrifuged and freeze-dried. The final material was dissolved in water to a concentration of 50 ,g/,ul or 2 x 10 -5 x I07 c.p.m./jl. The purity of the radiolabelled dermatan sulphate was checked by ionexchange h.p.l.c. on Mono Q as described previously (Lindblom et al., 1989) . The effluent was monitored for 1251 radioactivity, for u.v. absorption at 275 nm and for glycosaminoglycan by the dimethylMethylene Blue method (Farndale et al., 1986 ) with a Multiscan photometer. The mass and all of the radiolabel appeared in the same position of the chromatogram (results not shown). Dermatan sulphate prepared by alkaline-borohydride treatment (0.5 M-NaOH/0.05 M-NaBH4 at room temperature overnight) was also subjected to radioiodination. Serine was 3-(4-hydroxyphenyl)propionylated and radiolabelled by the same procedure; the product was isolated by gel filtration (in water) on Sephadex G-25 packed in a disposable 1 cm x 10 cm column.
Degradation procedures
Cleavage of all hexosaminidic bonds in the main dermatan sulphate chain was performed with choridroitin ABC lyase in 10 mM-EDTA/0.1 M-Tris-acetate buffer, pH 7.3, at 37 0C. The same conditions were used for the cleavage of hexosaminidic bonds to D-GlcA by chondroitin AC-I lyase. The chondroitin AC-II lyase was used in a 50 mM-sodium acetate buffer, pH 6.0. Clustered GlcA-GalNAc units were cleaved by testicular hyaluronidase in 0.15 M-NaCl/50 mM-sodium acetate buffer, pH 5.5. Non-sulphated L-IdoA residues were selectively oxidized and cleaved as described previously (Fransson & Carlstedt, 1974) . Non-reducing terminal unsaturated uronic acids were removed by the mercuric salt procedure developed by Ludwigs et al. (1987) . Treatments with alkaline phosphatase and 8J-galactosidase (exoglycosidase) were as described previously . For further details see the legends to the appropriate Figures.
Gradient PAGE
The procedure used is based on the methods described by Rice et al. (1987) and Turnbull & Gallagher (1988) . We cast gels between glass plates that were 18 cm wide, 40 cm high and 0.75 mm apart using a vertical LKB stand and gradient mixer and a pump (Alitea, Sweden). The mixing chamber was filled with a weighed 22 ml solution of acrylamide/bisacrylamide (T 30 %; C 3.6 %) in 10 mM-EDTA/0. I M-Tris/0. I M-borate buffer, pH 8.3 (resolving gel buffer), containing 15 % (w/v) sucrose, as well as 10 ,u1 of NNN'N'-tetramethylethylenediamine and 100 ,ul of 10 % (w/v) ammonium persulphate as catalysts for the polymerization. The reservoir was filled with the same weight of acrylamide/bisacrylamide (T 20 %; C 0.5 %) in the same buffer containing 1 % (w/v) sucrose and the same amount of catalysts.
The solutions were pumped at a rate of 5 ml/min to form a linear gradient with a high concentration at the bottom and a low one at the top. The gel was allowed to form under 2-methylpropanl-ol for approx. 1 h and was then rinsed with resolving gel buffer. On top of this gel we cast a 5 ml stacking gel consisting of acrylamide/bisacrylamide (T 5 %; C 0.25 %) in 10 mm-EDTA/0.1 M-Tris/0.1 M-borate buffer, pH 6.3 (stacking gel buffer), containing the same amount of catalysts as above and with a ten-place comb to form the wells. The glass plates with the gels were then placed in a vertical electrophoresis unit (made in a local workshop) containing an upper and a lower reservoir. Before use the wells were rinsed and filled with 0.2 M-Tris/ 1.25 Mglycine buffer, pH 8.3 (upper reservoir buffer). The various samples were freeze-dried, dissolved in 10, l of 250% (w/v) sucrose in stacking gel buffer with or without 0.1 0% Bromophenol Blue and layered into the bottom of the wells with a Hamilton syringe (801 RNE). The lower reservoir contained resolving gel buffer. Electrophoresis was carried out for approx. 20 h with 600 V (constant voltage) and 8-10 mA. Standards were detected by using 0.080% Azure A in water followed by destaining in water. Radioiodinated compounds were located by placing the wet gel against X-ray film for 12-48 h at room temperature followed by development of the film. Tracks were scanned by videodensitometry in the transmittance mode.
RESULTS AND DISCUSSION Specificity of 125I-radiolabeliing of the Ser residue in dermatan sulphate preparations
The dermatan sulphates, exhaustively digested with proteinases, were radiolabelled with the use of Bolton-Hunter reagent (BHR) in a two-step procedure with the aim of introducing a radioactive marker exclusively at the reducing end of the chain. Control experiments showed that dermatan sulphate treated with alkaline borohydride incorporated less than 1 % of the amount of 1251 recovered in the 3-(4-hydroxyphenyl)-propionylated material.
To isolate and identify radiolabelled linkage-region fragments, i.e.
('25I)HOPh-[CH2]2-CO-HN-Ser-Xyl-Gal-Gal-GlcA-..., . The linkage-region fragment was purified by fast-desalting f.p.l.c. and ion-exchange h.p.l.c. In the latter procedure the expected linkage-region fragment was eluted after 47 min (Fig. la) ; remaining disaccharide emerged after 40 min (see the arrow). The radioiodinated and chondroitin ABC lyasetreated dermatan sulphate yielded a major labelled component that was also eluted after 47 min on ion-exchange h.p.l.c. (Fig. lb) . This fragment should have the structure AHexAGalNAc(-SO4)-GlcA-Gal-Gal-Xyl-Ser(-BHR). When the same dermatan sulphate was digested with both chondroitin ABC lyase and chondroitin AC-I lyase the major radiolabelled component emerged after 34 min (Fig. lc) . The latter fragment should have the structure AHexA-Gal-Gal-Xyl-Ser(-BHR), as chondroitin AC lyase removes the residual repeating disaccharide (see (Fig. 2, lane b) . Although a linkage-region fragment AHexA-GaINAc(-SO4)-GIcA-Gal-GalXyl-Ser(-BHR) is approximately of hexasaccharide size, its charge density is lower than that of a regular hexasaccharide, [HexA-GalNAc(-SO4)]3. Chondroitin ABC lyase as well as combined chondroitin ABC lyase and chondroitin AC-I lyase digests of radioiodinated dermatan sulphate were run in lanes d and e respectively (Fig. 2) The major linkage-region fragment obtained from radiolabelled dermatan sulphate after combined chondroitin ABC lyase and chondroitin AC-I lyase treatments, and isolated as described in Fig. l(c) , was homogeneous on electrophoresis (lane f in Fig. 2 ). This component should have a non-reducing terminal unsaturated uronic acid (AHexA), which was removed by treatment with HgCl2 followed by passage through Dowex 50 (Ludwigs et al., 1987) . The product, which had lost a charged residue, migrated to a more retarded position (lane g in Fig. 2 ). There was also another, even more retarded, component, which disappeared upon incubation in an aqueous buffer (lane h). The component in lane h should have the structure Gal-Gal-Xyl- Ser(-BHR), i.e. a blocked N-terminus and a negatively charged C-terminus. To demonstrate that it contained non-reducing terminal Gal, it was digested with fl-galactosidase. As shown in lane i in Fig. 2 (see Fig. 3c ; for references see . Hence the longest discernible fragment contained 30 repeating units, corresponding to an Mn of at least 15 000, which is in good agreement with the estimated average size of the intact chains (M. 17 500).
When the same dermatan sulphate was treated with corresponding amounts of chondroitin AC-I lyase for the same periods of time, the major product was a linkage-region fragment with the expected structure AHexA-Gal-Gal-Xyl-Ser(-BHR) ( Fig. 3b; for references see . As this component was the major one even after very short periods of incubation, we conclude that the sequence nearest to the peptide is always -GalNAc-GlcA-Gal-Gal-Xyl-Ser. In many chains of this preparation this may be the only GlcA residue.
Partial degradation of end-labelled dermatan sulphate by oxidation-elimination
The major uronic acid in dermatan sulphate is IdoA, which can be 2-O-sulphated to a minor extent . Nonsulphated IdoA can be oxidized with periodate under conditions (low pH and temperature) that preclude oxidation of GIcA. Fig. 2, lane c) to the left. LR indicates the position of linkage-region fragment GIcA-GalNAc(-S04)-GlcAGal-Gal-Xyl-Ser (Fransson, 1968) .
Ido-A-SO4 is, of course, always inaccessible to oxidation. Moreover, non-substituted Xyl in the linkage region (see above) has a periodate-sensitive glycol group; a phosphorylated Xyl residue would be periodate-resistant. Hence periodate oxidation of endlabelled dermatan sulphate followed by base-catalysed elimination and electrophoresis can be used to assess the degree of substitution of Xyl as well as to provide information about the distribution of non-sulphated Ido-A. Both phosphatase-treated and untreated dermatan sulphates DS-18 and DS-36 (obtained via papain proteolysis only) were subjected to this analysis. All preparations afforded major bands ranging from intact chains down to approximately the decasaccharide standard, indicating that most of the non-sulphated IdoA was located distally. Only the result of a 1 h oxidation of preparation DS-36 is shown here (Fig. 4, lane a) . Direct comparison of the banding pattern obtained after brief oxidation (Fig. 4, lane a) with that obtained after partial chondroitin ABC lyase digestion (Fig. 4, lane b) indicated that the periodate-oxidation products corresponding to the first three repeating disaccharide positions (see also Fig. 3 . Dermatan sulphate preparation DS-36 (obtained after papain proteolysis) was 3-(4-hydroxphenyl)propionylated, radiolabelled and degraded partially by testicular hyaluronidase followed by electrophoresis (Fig. 6) . Two preparations were used, one of which had been treated with alkaline phosphatase before derivative formation. As shown in Fig. 6 , untreated dermatan sulphate (Fig. 6a ) and alkaline-phosphatase-treated dermatan sulphate (Fig. 6b) afforded very similar patterns. These fragments should have the general structure [HexA-GalNAc(-SO4)]n-GlcA-Gal-Gal-Xyl-Ser (-BHR) where n corresponds to the number of disaccharide repeats (see also Fig. 3 ). The shortest fragment migrated like the standard GlcA-GalNAc(-SO4)-GlcA-Gal-Gal-Xyl-Ser (LR in Fig. 6 ), and components ranging from this position (n = 1) up to approx. n = 20 could be identified. In addition, there was a band in the decasaccharide position that did not correspond to the regular pattern. This could be an undersulphated version of a fragment with n = 2. Furthermore, the intensity of the bands varied, particularly after short incubation times, suggesting that clustered GlcA-GaINAc repeats were distributed periodically in a nonrandom fashion. The densitometric scan of the track obtained after a 2 min incubation (Fig. 6c ) indicated again that GIcA was prevalent in positions 1-3, 7-12 and possibly also between 20 and 30 from the linkage region.
As testicular hyaluronidase has transglycosylative activity, fragments could theoretically be extended by a few repeats, which would give erroneous results. To prevent such extensions, non-reducing terminal GlcA was removed by carrying out the digestions with testicular hyaluronidase in the presence of a large Oligosaccharide standards Fig. 7 . Densitometric scans of electrophoretograms of end-labelled dermatan sulphate partially degraded with testicular hyaluronidase in the absence (a and c) or in the presence (b and d) of an excess of /I-glucuronidase Dermatan sulphate preparation DS-36 was 3-(4-hydroxyphenyl)-propionylated and radiolabelled as described in the Experimental section. Samples were partially degraded with testicular hyaluronidase as described in the legend to Fig. 6 in the absence or in the presence of 5000 units of ,-glucuronidase. After electrophoresis and autoradiography the tracks were scanned by. videodensitometry. The tracks are (a and b) digestions for 1 h or (c and d) digestions for 4 h. LR indicates the position of linkage-region fragment GlcA-GalNAc(-SO4)-GlcA-Gal-Gal-Xyl-Ser (Fransson, 1968) . excess of #-glucuronidase. The results showed (Fig. 7) (Figs. 7a and 7c ).
General discussion
Here we present a procedure for the sequence analysis of dermatan sulphate. This glycosaminoglycan is generally present in small proteoglycans (PG-S I or biglycan and PG-S2 or decorin) in only one or two positions (see Heinegaird & Sommarin, 1987; Ward et al., 1987; Ruoslahti, 1988; Choi et al., 1989; Melching & Roughley, 1989 (d) available the specific radioactivity can probably be increased further. The procedure described in the present study should be useful for analysing the glycosaminoglycan chains of other proteoglycans provided that they are relatively sparsely substituted and that acidic amino acids as well as N-or 0-linked oligosaccharides near the linkage Ser residue can be removed.
Extensive degradation of reducing end-labelled pig skin dermatan sulphate with chondroitin ABC lyase produced a linkage-region fragment of the proposed structure AHexAGalNAc(-SO4)-GlcA-Gal-Gal-Xyl-Ser(-BHR). This fragment was eroded stepwise, first by chondroitin AC lyase (either type I or II) to AHexA-Gal-Gal-Xyl-Ser(-BHR), then by HgCl2 to GalGal-Xyl-Ser(-BHR), and finally to Xyl-Ser(-BHR). by figalactosidase. As most of the Gal could be removed by this enzyme, there are probably very few Gal-SO4 residues (Sugahara et al., 1988) . The Xyl residues in the linkage region of pig skin dermatan sulphate are largely unsubstituted, because they were extensively cleaved by periodate oxidation even before treatment with alkaline phosphatase. It is possible that only newly synthesized dermatan sulphates carry phosphorylated Xyl residues (Gl6ssl et al., 1986) .
The pig skin dermatan sulphate used in this study comprises chains with various GlcA contents, probably ranging from one to eight residues per chain (Fransson et al., 1979) . The present results confirm that the position next to Gal-Gal-Xyl-Ser is always occupied by GlcA (Fransson, 1968) . The next three disaccharide repeats also seem to be GlcA-rich, whereas positions 4, 5 and possibly 6 often have IdoA. In the next four or five repeats GIcA is again more common. Clustered GlcA-GalNAc repeats seem to peak at positions 1-3, 8-9 and again around 25. Although the dermatan sulphates analysed here were probably derived from more than one type of proteoglycan secreted from different types of cells, the results indicate that the GlcA-GalNAc repeats have a periodic and non-random distribution. The pattern may be more distinct when the analysis is applied to glycosaminoglycan chains from a specific site in a particular proteoglycan made by one cell type at a defined stage of maturation. By determining the GlcA content in reducing endlabelled fragments of different sizes produced by chemical depolymerization of pig skin dermatan sulphate Uchiyama & Nagasawa (1987) arrived at similar conclusions to those described here. It should be pointed out, however, that there must be chains that contain IdoA in nearly all of the available positions.
Moreover, we have not determined the location of IdoA-SO4.
Coupling of the reducing end of heparin (Radoff & Danishefsky, 1984; Rosenfeld & Danishefsky, 1988) or the peptide portion of heparan sulphate proteoglycans (Lyon et al., 1987) (Lyon et al., 1987) . In heparin, the first antithrombin-binding sequence is 20 disaccharide units away from the carbohydrate-protein linkage (Rosenfeld & Danishefsky, 1988) . Other studies indicate that the building blocks in heparin are generally non-random (Linhardt et al., 1989) . Especially, repeats that have not been fully processed during biosynthesis occur in an ordered fashion. Moreover, regions of heparin that are processed in a special manner, e.g. the antithrombin-binding sequence, are markedly non-random when the intact heparin chains of a heparin proteoglycan are examined (Jacobsson et al., 1986) . However, heparin fragments generated by endoglucuronidase action do not seem to have an ordered distribution of the antithrombin-binding sites (Linhardt et al., 1989; Oscarsson et al., 1989) .
